SureTrader SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 9/4/2015 7:20:14 AM - Followers: 642 - Board type: Free - Posts Today: 5

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

http://cellceutix.com/wp-content/uploads/2015/06/Cellceutix-Fact-Sheet-June-2015-flattened-1.pdf

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
PostSubject
#120806  Sticky Note $CTIX recent news/filings TheHound 09/03/15 10:29:02 AM
#120460  Sticky Note Cellceutix’s Prurisol: A Potential Blockbuster Psoriasis Treatment TOB 08/28/15 03:20:01 PM
#119441  Sticky Note Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting starbuxsux 08/20/15 03:41:27 PM
#118219  Sticky Note $CTIX - My visit to Cellceutix, the biotech KarinCA 08/14/15 02:19:08 PM
#117849  Sticky Note The topic to be discussed here is CTIX. IH Admin [Dan] 08/12/15 12:28:39 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#120871   I made like a judge and yanked out scottsmith 09/04/15 07:20:14 AM
#120870   LR - well put. With all this background Amatuer17 09/04/15 06:22:36 AM
#120869   FINRA short sales of CTIX = MISLEADING DATA NanoEngineer 09/04/15 05:57:30 AM
#120868   "Before applying they already applied" loanranger 09/04/15 04:49:26 AM
#120867   The comment: "...market will ignore any good news loanranger 09/04/15 03:48:27 AM
#120866   Before applying they already applied Whoops 09/03/15 10:54:29 PM
#120865   This is going nowhere but up from here! TheHound 09/03/15 10:53:22 PM
#120864   It's been a CTIX short sellers money making etradeedge 09/03/15 10:16:03 PM
#120863   How do you figure the market ignored ODD, scottsmith 09/03/15 10:01:49 PM
#120862   Uplisting to Nasdaq - will it happen Amatuer17 09/03/15 09:55:49 PM
#120860   This information is false. TheHound 09/03/15 09:02:38 PM
#120859   FINRA short sales of CTIX AlanC 09/03/15 08:21:12 PM
#120858   If I was a holder it wouldn't concern loanranger 09/03/15 07:51:10 PM
#120857   LR it's just my personal concern regarding the 58nout 09/03/15 07:19:32 PM
#120856   You got me back on board based on this.... loanranger 09/03/15 07:15:25 PM
#120855   Ah Phteven you haven't been here long enough 58nout 09/03/15 07:09:51 PM
#120854   LR, yes I'm referring to "net tangible assets". 58nout 09/03/15 07:01:29 PM
#120853   Pig MRSA Superbug Spreading To Humans Through Pork CallMeCrazy 09/03/15 05:31:53 PM
#120852   I would add that a mid/late Phase 2 Waverunner1 09/03/15 05:04:10 PM
#120851   I agree on the 3 to 4 yr Waverunner1 09/03/15 04:41:37 PM
#120850   Thanks for stopping by. Have any more scottsmith 09/03/15 04:10:38 PM
#120849   I've never changed. Always long and strong. Phteven C 09/03/15 04:04:47 PM
#120848   Potential is real here Good luck everyone! Cbdpotential 09/03/15 04:01:54 PM
#120846   This is 2015. I do not think we NOTPERFECT 09/03/15 03:57:16 PM
#120845   I see they have a "nice" little 5 keltoi 09/03/15 03:46:49 PM
#120844   "The ASPIRE transactions and the cash." loanranger 09/03/15 03:24:22 PM
#120843   Huge things coming in 2018. GO CTIX! Phteven C 09/03/15 03:17:36 PM
#120842   Doldrums. Much preferable to short attack, but boring. noretreat 09/03/15 03:11:42 PM
#120841   Why do you reckon next week? Sounds like Phteven C 09/03/15 02:12:21 PM
#120839   I'd say a nice strong close around 2.05 Ringrock 09/03/15 01:50:47 PM
#120838   I reckon update is coming next week... faraifarai 09/03/15 01:49:59 PM
#120837   In addition I will be interested in some Amatuer17 09/03/15 01:49:08 PM
#120836   10K due any day now. We should all 58nout 09/03/15 01:19:59 PM
#120835   do you see a change in recruitment contact? govorchin 09/03/15 01:04:01 PM
#120834   No change in date in the history of BigKahuna 09/03/15 01:00:44 PM
#120833   There has been no change in the Brilacidin-OM TOB 09/03/15 01:00:29 PM
#120832   It's a Mexican standoff - one party is rule_rationale 09/03/15 12:56:41 PM
#120831   i thought the first date was dec 2015. govorchin 09/03/15 12:56:30 PM
#120829   Hasn't it always been the 2016 time frame?? morecoffee 09/03/15 12:42:23 PM
#120828   7 cent spread on the bid and ask... BioHedge 09/03/15 12:30:30 PM
#120827   So true but one still has to know oldguy76 09/03/15 12:27:45 PM
#120826   Whoa nice reversal joseytheoutlawwales 09/03/15 12:20:13 PM
#120825   Yep. All of our P2s are a late Phteven C 09/03/15 12:19:51 PM
#120824   i would if i was more mobil. govorchin 09/03/15 12:19:23 PM
#120823   Gov -- I understand that you are an scottsmith 09/03/15 12:17:48 PM
#120822   completion dates for B-OM trial changed on clinical govorchin 09/03/15 12:14:40 PM
#120821   This is going Boooooooom soon BobbyKIrk 09/03/15 12:14:00 PM
#120820   $2.30 is in our crosshairs. TheHound 09/03/15 12:12:49 PM
#120819   Even a clock is right at least twice BigKahuna 09/03/15 12:11:16 PM
#120818   $2.00!!! Nice call by Kahuna! TheDane 09/03/15 12:05:08 PM
PostSubject